vs
Side-by-side financial comparison of Solid Power, Inc. (SLDP) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $3.6M, roughly 1.5× Solid Power, Inc.). On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs -18.6%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs -21.9%).
Solid Energy was the largest coal mining company in New Zealand and is a state owned enterprise of the New Zealand Government.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
SLDP vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.6M | $5.5M |
| Net Profit | — | $-27.9M |
| Gross Margin | — | — |
| Operating Margin | -730.1% | -516.0% |
| Net Margin | — | -507.8% |
| Revenue YoY | -18.6% | 171.3% |
| Net Profit YoY | — | -48.3% |
| EPS (diluted) | $-0.15 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.6M | $5.5M | ||
| Q3 25 | $3.7M | $0 | ||
| Q2 25 | $6.5M | $2.0M | ||
| Q1 25 | $6.0M | $2.3M | ||
| Q4 24 | $4.5M | $2.0M | ||
| Q3 24 | $4.7M | $1.8M | ||
| Q2 24 | $5.1M | $1.1M | ||
| Q1 24 | $6.0M | $3.4M |
| Q4 25 | — | $-27.9M | ||
| Q3 25 | $-25.9M | $-32.7M | ||
| Q2 25 | $-25.3M | $-26.9M | ||
| Q1 25 | $-15.2M | $-21.5M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-22.4M | $-25.5M | ||
| Q2 24 | $-22.3M | $-20.9M | ||
| Q1 24 | $-21.2M | $-24.1M |
| Q4 25 | -730.1% | -516.0% | ||
| Q3 25 | -654.4% | — | ||
| Q2 25 | -398.9% | -1347.1% | ||
| Q1 25 | -399.4% | -930.5% | ||
| Q4 24 | -561.1% | -985.8% | ||
| Q3 24 | -593.2% | -1448.4% | ||
| Q2 24 | -530.8% | -1915.4% | ||
| Q1 24 | -433.1% | -713.3% |
| Q4 25 | — | -507.8% | ||
| Q3 25 | -693.1% | — | ||
| Q2 25 | -390.7% | -1353.6% | ||
| Q1 25 | -251.8% | -935.2% | ||
| Q4 24 | — | -929.0% | ||
| Q3 24 | -482.0% | -1427.5% | ||
| Q2 24 | -438.9% | -1882.0% | ||
| Q1 24 | -356.2% | -705.4% |
| Q4 25 | $-0.15 | $-0.08 | ||
| Q3 25 | $-0.14 | $-0.09 | ||
| Q2 25 | $-0.14 | $-0.09 | ||
| Q1 25 | $-0.08 | $-0.08 | ||
| Q4 24 | $-0.16 | $-0.07 | ||
| Q3 24 | $-0.13 | $-0.10 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.12 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $250.8M | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $415.7M | $246.9M |
| Total Assets | $455.1M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $250.8M | $319.8M | ||
| Q3 25 | $251.2M | $297.3M | ||
| Q2 25 | $230.9M | $312.8M | ||
| Q1 25 | $240.9M | $116.6M | ||
| Q4 24 | $118.2M | $139.0M | ||
| Q3 24 | $132.0M | $157.7M | ||
| Q2 24 | $140.5M | $172.7M | ||
| Q1 24 | $146.6M | $124.0M |
| Q4 25 | $415.7M | $246.9M | ||
| Q3 25 | $381.2M | $219.0M | ||
| Q2 25 | $370.6M | $248.7M | ||
| Q1 25 | $397.1M | $55.1M | ||
| Q4 24 | $410.3M | $71.5M | ||
| Q3 24 | $439.4M | $88.8M | ||
| Q2 24 | $456.8M | $108.9M | ||
| Q1 24 | $479.4M | $53.8M |
| Q4 25 | $455.1M | $343.3M | ||
| Q3 25 | $416.1M | $316.6M | ||
| Q2 25 | $398.0M | $333.3M | ||
| Q1 25 | $419.4M | $138.4M | ||
| Q4 24 | $448.3M | $160.4M | ||
| Q3 24 | $470.9M | $180.2M | ||
| Q2 24 | $492.6M | $200.4M | ||
| Q1 24 | $516.2M | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.4M | $-26.7M |
| Free Cash FlowOCF − Capex | $-23.0M | — |
| FCF MarginFCF / Revenue | -633.0% | — |
| Capex IntensityCapex / Revenue | 126.5% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-83.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.4M | $-26.7M | ||
| Q3 25 | $-14.3M | $-24.2M | ||
| Q2 25 | $-14.4M | $-20.2M | ||
| Q1 25 | $-26.3M | $-22.0M | ||
| Q4 24 | $-13.9M | $-18.3M | ||
| Q3 24 | $-9.9M | $-21.6M | ||
| Q2 24 | $-11.1M | $-21.5M | ||
| Q1 24 | $-29.1M | $-19.8M |
| Q4 25 | $-23.0M | — | ||
| Q3 25 | $-14.8M | $-24.3M | ||
| Q2 25 | $-17.1M | — | ||
| Q1 25 | $-28.6M | — | ||
| Q4 24 | $-18.6M | $-18.3M | ||
| Q3 24 | $-12.6M | $-21.6M | ||
| Q2 24 | $-15.5M | $-21.7M | ||
| Q1 24 | $-33.1M | $-19.9M |
| Q4 25 | -633.0% | — | ||
| Q3 25 | -397.6% | — | ||
| Q2 25 | -264.2% | — | ||
| Q1 25 | -476.1% | — | ||
| Q4 24 | -416.5% | -905.5% | ||
| Q3 24 | -271.5% | -1210.9% | ||
| Q2 24 | -305.8% | -1951.9% | ||
| Q1 24 | -556.3% | -584.5% |
| Q4 25 | 126.5% | — | ||
| Q3 25 | 15.3% | — | ||
| Q2 25 | 41.5% | — | ||
| Q1 25 | 39.1% | — | ||
| Q4 24 | 105.5% | 0.1% | ||
| Q3 24 | 59.7% | 2.0% | ||
| Q2 24 | 86.8% | 18.1% | ||
| Q1 24 | 68.1% | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
